Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL 101: Biology, Symptoms, and Diagnosis

CLL 101: Biology, Symptoms, and Diagnosis Banner

Wednesday, March 26 at 11:30 AM – 1 PM PT, 12:30 – 2 PM MT, 1:30 – 3 PM CT, 2:30 – 4 PM ET 
 (Duration 90 minutes)

Description

Join CLL Society for an engaging and informative webinar designed to provide a comprehensive introduction to chronic lymphocytic leukemia (CLL). Whether you’re newly diagnosed, have been living with CLL for decades, or supporting a loved one on their journey, this session will cover the key aspects of CLL in an accessible and easy-to-understand format.

Nurse Practitioner Josie Montegaard will present on the basics of CLL, including its biology, the distinction between CLL and SLL, its classification as a chronic disease, symptoms and how it presents, diagnosis and testing, as well as potential causes, including genetic and environmental factors. CLL patient advocate Stephen Feldman will share important resources and help moderate your questions.

The webinar will be geared towards beginners.

Speakers

Welcome:
RB Headshot 2_Color_July 2023

Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research
CLL Society

Moderator and Speaker:
Stephen Feldman - CLL Society

Stephen Feldman
CLL Patient Advocate

Speaker:
Josie

Josie Montegaard, MSN AGPCNP-BC
Nurse Practitioner
Dana-Farber Cancer Institute
Boston, MA

Advanced Questions:

Ask your question in advance of the event by emailing [email protected] by Monday, March 24th. Please include “CLL 101 Webinar” in the subject line.

Questions asked in advance are provided to the speaker in preparation for the event. Questions that are applicable to more than one person and succinctly written to have broad interest have a higher chance of being asked by the moderator.

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.

This program was made possible by generous donors and grant support from Genentech.